Surface Oncology, Inc. - Common Stock (NQ:SURF)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 7, 2023 Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	1.030 (21)
Ask (Size)	1.090 (10)
Prev. Close	1.070
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	45,452,450
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences

August 31, 2023

Urges Stockholders to Vote Promptly to Ensure Their Shares are Represented at the September 7th Special Meeting

From Surface Oncology, Inc.

Via GlobeNewswire

SURFACE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF

August 07, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Performance

More News

Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023

August 02, 2023

From Surface Oncology, Inc.

Via GlobeNewswire

Health Care Company Coherus BioSciences Announces Merger With Surface Oncology ↗

June 16, 2023

Via Benzinga

Recap: Surface Oncology Q1 Earnings ↗

May 04, 2023

Via Benzinga

Downgrade Aside, Cathie Wood Buys $1.2M Worth Of SoFi Shares ↗

July 27, 2023

Via Benzinga

Cathie Wood's Ark Pours $3.3M More Into This Chipmaker Amid AI Frenzy: Here Are Other Major Monday Trades ↗

July 11, 2023

Via Benzinga

Cathie Wood's Ark Outshines S&P 500, Nasdaq In H1: Here Are The Major Trades It Made ↗

June 28, 2023

Via Benzinga

Cathie Wood Sells $7M Tesla Stock Friday Amid Pullback, Bets Big On This Crypto-Linked Stock ↗

June 24, 2023

Via Benzinga

SURFACE ONCOLOGY INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF

June 21, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Synergy Of Coherus And Surface Oncology: Analyst Forecasts $50M Savings And 2024 Profitability ↗

June 20, 2023

Via Benzinga

Nasdaq Down 80 Points; US Consumer Sentiment Surges To 4-Month High In June ↗

June 16, 2023

Via Benzinga

Crude Oil Rises; Adobe Posts Upbeat Results ↗

June 16, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 20, 2023 ↗

June 20, 2023

Via Benzinga

Coherus BioSciences, MicroVision, Millicom And Other Big Stocks Moving Lower On Friday ↗

June 16, 2023

Via Benzinga

Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 16, 2023

Via Benzinga

SURF Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Surface Oncology, Inc. Is Fair to Shareholders

June 16, 2023

From Halper Sadeh LLC

Via Business Wire

US Stocks Mixed; Dow Gains 50 Points ↗

June 16, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 16, 2023

Via Benzinga

Coherus BioSciences Acquires Small Immuno-Oncology Player Surface Oncology For $40M ↗

June 16, 2023

Via Benzinga

Coherus to Acquire Surface Oncology

June 16, 2023

From Surface Oncology, Inc.

Via GlobeNewswire

Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2023

May 04, 2023

From Surface Oncology, Inc.

Via GlobeNewswire

Surface Oncology Presents New Preclinical Data on SRF114, a fully human anti-CCR8 antibody, at the AACR Annual Meeting 2023

April 18, 2023

From Surface Oncology, Inc.

Via GlobeNewswire

Surface Oncology to Present New Preclinical SRF114 Data at the American Association for Cancer Research (AACR) Annual Meeting 2023

March 16, 2023

From Surface Oncology, Inc.

Via GlobeNewswire

Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2022

March 09, 2023

From Surface Oncology, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Surface Oncology, Inc. - Common Stock publicly traded?

Yes, Surface Oncology, Inc. - Common Stock is publicly traded.

What exchange does Surface Oncology, Inc. - Common Stock trade on?

Surface Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Surface Oncology, Inc. - Common Stock?

The ticker symbol for Surface Oncology, Inc. - Common Stock is SURF on the Nasdaq Stock Market